Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Procaps Group S.A.
Procaps Group S.A. News
Apr 28, 2025 - globenewswire.com
Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC
Apr 9, 2025 - globenewswire.com
Procaps Group Secures $130 Million in Equity Investment and Completes Comprehensive Debt Restructuring, as New Investors Take Over Strategic Leadership
Procaps Group S.A. Quantitative Score
About Procaps Group S.A.
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.
Procaps Group S.A. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Procaps Group S.A. Financials
Table Compare
Compare PROC metrics with: | |||
|---|---|---|---|
Earnings & Growth | PROC | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | PROC | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | PROC | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | PROC | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Procaps Group S.A. Income
Procaps Group S.A. Balance Sheet
Procaps Group S.A. Cash Flow
Procaps Group S.A. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Strong Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Procaps Group S.A. Executives
| Name | Role |
|---|---|
| Mr. Luis Alberto Palacios Aragon | Vice-President of International Marketing and R&D |
| Ms. Marcela Carvajalino Pagano | Vice-President of Corporate & Legal Affairs |
| Mr. Jose Antonio Toledo Vieira | Chief Executive Officer |
| Mr. Patricio Vargas Munoz | Chief Optimization and Rationalization Officer |
| Mr. Mauricio Castaneda Caballero | Vice-President of Human Resources |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Luis Alberto Palacios Aragon | Vice-President of International Marketing and R&D | Male | 1964 | -- |
| Ms. Marcela Carvajalino Pagano | Vice-President of Corporate & Legal Affairs | Female | 1967 | -- |
| Mr. Jose Antonio Toledo Vieira | Chief Executive Officer | Male | 1967 | -- |
| Mr. Patricio Vargas Munoz | Chief Optimization and Rationalization Officer | Male | 1973 | -- |
| Mr. Mauricio Castaneda Caballero | Vice-President of Human Resources | Male | 1977 | -- |